Sumitomo Pharma America Highlights Early Myelofibrosis and Leukemia Findings at EHA 2026
As reported on PharmaBiz, Sumitomo Pharma America (SMPA) presented new clinical and translational data spanning myelofibrosis (MF) and acute leukemia programs at the 2026 European Hematology Association Congress in Stockholm…